Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Creso Pharma sees ‘major opportunity’ after TGA interim decision
Health & Biotech
ASX pot stocks are getting high after TGA interim ruling
Stockhead TV
StockTalk: Animal health is a $67bn hidden gem
Health & Biotech
Animal health: The $67bn hidden gem of the global healthcare market
Health & Biotech
Creso Pharma wins second Israeli order for its medicinal cannabis
Health & Biotech
Creso Pharma streamlines Canada production ahead of launch
Health & Biotech
Creso Pharma’s Canadian retail sales set to start
Health & Biotech
Creso Pharma’s South Africa sales begin with Cannamics
Health & Biotech
Creso is perfectly poised for growth in the huge Brazilian market
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Creso Pharma continues global distribution push with new strategic partnership into Pakistan
Health & Biotech
Creso Pharma’s latest anibidiol shipment to Virbac makes over $200k in revenue
Health & Biotech
Creso Pharma breaks into lucrative Israeli market, streaks past 2019 revenues
Health & Biotech
Creso Pharma successfully delivers its first shipment of cannaQIX® to South Africa for launch in Q2
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech